Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2022-06-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
湖南启元律师事务所关于益丰大药房连锁股份有限公司2019年限制性股票激励计划首次授予的限制性股票第三期解锁暨上市的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the unlocking and listing of restricted shares under a 2019 restricted stock incentive plan for a company. It details the approval, implementation, unlocking conditions, and stock structure changes related to the stock incentive plan. It is not a financial report, earnings release, or management discussion, but a legal opinion related to stock incentive plan implementation and compliance with relevant laws and regulations. This type of document fits best under Regulatory Filings (RNS) as it is a legal opinion and compliance document rather than a financial or management report.
2022-06-27 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司使用可转换公司债券部分闲置募集资金暂时补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the use of idle raised funds from a convertible bond issuance by Yifeng Pharmacy Chain Co., Ltd. It discusses the approval, regulatory compliance, and internal decision-making related to temporarily supplementing working capital with part of the idle raised funds. The document references regulatory guidelines and approvals but does not contain financial statements or quarterly/yearly financial results. It is a formal audit or verification report on the use of funds, not an annual or interim financial report, earnings release, or capital update. Therefore, it fits best under Audit Report / Information (AR) as it is a standalone audit/verification report on the use of raised funds. FY 2022
2022-06-27 Chinese
益丰药房关于使用可转换公司债券部分闲置募集资金暂时补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the use of idle raised funds from convertible bonds to temporarily supplement working capital. It includes details about the amount of funds raised, approvals from the board and supervisory committee, independent director opinions, and regulatory compliance statements. The document does not contain financial statements or detailed financial performance data but focuses on the company's capital usage plan and regulatory compliance related to fundraising. It is not a full financial report, earnings release, or management discussion. The document is a formal announcement about capital usage and financing activities, fitting the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about capital usage rather than just announcing a report publication, so it is not an RPA. Therefore, the best classification is CAP with high confidence.
2022-06-27 Chinese
益丰药房第四届监事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Yifeng Pharmacy Chain Co., Ltd. It details the meeting date, attendance, and voting results on several proposals including stock incentive plan unlocks, a bank loan application for acquisition, and the use of idle raised funds for working capital. The content focuses on board-level decisions and approvals rather than financial results, earnings, or audit information. There is no indication of a full annual or interim report, earnings release, or audit report. The document is not a report publication announcement as it contains substantive meeting resolutions and voting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management bodies. Confidence is high given the detailed meeting and voting information and the nature of the content.
2022-06-27 Chinese
益丰药房2021年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the distribution of dividends for the 2021 fiscal year by 益丰大药房连锁股份有限公司. It details the dividend per share, relevant dates for dividend distribution, tax implications, and the approval of the dividend plan at the 2022 shareholders' meeting. The content focuses on dividend amounts, payment dates, and shareholder instructions, which aligns with the definition of a Notice of Dividend Amount (DIV). The document length is short (2324 characters) and contains specific dividend details rather than a full financial report or other types of filings.
2022-06-21 Chinese
益丰药房关于实际控制人股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the actual controller of the company, Mr. Gao Yi. It details the number of shares released from pledge, the dates of pledge and release, and the current status of share pledges. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge status, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like share issue, director dealings, or capital updates. The document length is short and it is an announcement rather than a report.
2022-06-17 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.